ADP
64
2
HP
38
-2
AMAT
36
5
K
53
2
COF
55
-3
EXC
54
-2
IP
70
2
VLO
40
-2
SO
55
-2
T
50
3
VTR
49
-3
APA
21
2
RSG
68
3
GRMN
62
-3
DVN
16
3
NTAP
64
2
IR
63
3
ZBH
60
-2
HUM
48
6
DG
2
-6
ADP
64
2
HP
38
-2
AMAT
36
5
K
53
2
COF
55
-3
EXC
54
-2
IP
70
2
VLO
40
-2
SO
55
-2
T
50
3
VTR
49
-3
APA
21
2
RSG
68
3
GRMN
62
-3
DVN
16
3
NTAP
64
2
IR
63
3
ZBH
60
-2
HUM
48
6
DG
2
-6
Financhill
Back

Delek US Holdings 10K Form

Sell
27

DK
Delek US Holdings

Last Price:
18.39
Seasonality Move:
7.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DK News And Ratings

See the #1 stock for the next 7 days that we like better than DK

DK Financial Statistics

Sales & Book Value

Annual Sales: $16.92B
Cash Flow: $-125.8M
Price / Cash Flow: 0
Annual Sales: $11.05
Price / Book: 1.71

Profitability

EPS (TTM): -4.86000
Net Income (TTM): $-311.5M
Gross Margin: $683.2M
Return on Equity: -31.09%
Return on Assets: -4.3%

Delek US Holdings Earnings Forecast

Key Delek US Holdings Financial Ratios

  • The Gross Profit Margin over the past 22 years for DK is 4.04%.
  • The Selling, General & Administrative Expenses for DK have been equal to 1.69% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 1,607.07% of Operating Income.
  • The Net Earning history of DK is 0.12% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 11 years.

Delek US Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Oil, Gas & Consumable Fuels
Sector: Energy
Current Symbol: DK
CUSIP: 24665A
Website: delekus.com

Debt

Debt-to-Equity Ratio: 3.97
Current Ratio: 1.04
Quick Ratio: 0.65

Price-to-Earnings

Trailing P/E Ratio: 62.2
Forward P/E Ratio: 0

DK Technical Analysis vs Fundamental Analysis

Sell
27
Delek US Holdings (DK) is a Sell

Is Delek US Holdings a Buy or a Sell?

  • Delek US Holdings stock is rated a Sell
    The current Delek US Holdings [DK] share price is $18.04. The Score for DK is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.